Qatar’s premier not-for-profit health care provider Hamad Medical Corporation (HMC) has signed a three-year framework contract agreement with the region’s leading Pharmaceutical Company Qatar Pharma for Pharmaceutical Industries to supply medicines and medical supplies.
This agreement is part of the Ministry of Commerce and Industry’s and Hamad Medical Corporation’s collaborative efforts to encourage national industries and demonstrate the capabilities of local products to secure Qatar’s self-sufficiency.
“This cooperation came within the framework of the Ministry’s efforts aimed at supporting the role of national companies in achieving self-sufficiency in its various sectors, especially in the field of pharmaceutical industries, which represents one of the vital sectors at the national and international levels. The initiative instills a true partnership with the private sector, and supports the economic growth of non-oil sectors, in line with the economic diversification plans pursued by Qatar to achieve the objectives of its National Vision 2030 and Qatar National Manufacturing Strategy 2018-2022.”
Mr. Abdulbasit Talib Al-Ajji, Director of the National Product Competitiveness Support Department at the Ministry, commented that the agreement is part of the Ministry’s ongoing efforts to support national industries in Qatar by coordinating and connecting manufacturers and suppliers with government agencies in Qatar to make purchasing local products easier and more competitive against imported goods, thereby protecting national products and increasing consumer access to them.
He further added that signing the agreement comprised the outset of works that would be completed by signing agreements and contracts with other manufacturers within the medical and other sectors during the coming period.
Dr. Ahmed Mohamed Al Sulaiti, Chairman of Qatar Pharma for Pharmaceutical Industries stated that the signing of the deal with Hamad Medical Corporation showed the government’s efforts to promote the industrial sectors, particularly the pharmaceutical industry, which is a major revenue generator in the country.
“This agreement will open up broader horizons and fields for the development of the pharmaceutical industry and will expand the establishment of more factories to meet the State’s increasing needs,” Dr. Al Sulaiti added.